Dermal changes in superficial basal cell carcinoma, melanoma in situ and actinic keratosis and their implications

Journal of Cutaneous Pathology

Volumn 40, Issue 12, 2013, Pages 1014-1020

  Kazlouskaya, Viktoryia ^a   Malhotra, Saurabh ^b   Navarro, Raquel ^c   Wu, Karen Nguyen ^a   Shvartsbeyn, Marianna ^d   Shengli, Chen ^e   Gui, Jiang ^f   Elston, Dirk M ^a  

^a ACKERMAN ACADEMY OF DERMATOPATHOLOGY   (United States)

^b DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^c HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^d NEW YORK UNIVERSITY   (United States)

^e Shandong Provincial Institute of Dermatology and Venereology   (China)

^f DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

cancer; malignant melanoma; non melanoma skin cancer; pathology; pathology dermatopathology

Indexed keywords

ACTINIC KERATOSIS; ARTICLE; BASAL CELL CARCINOMA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DERMIS; FEMALE; HUMAN; MALE; MELANOMA; NEOPLASM; NON-MELANOMA SKIN CANCER; PATHOLOGY; PATHOLOGY DERMATOPATHOLOGY; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY; SKIN TUMOR;

CANCER; MALIGNANT MELANOMA; NON-MELANOMA SKIN CANCER; PATHOLOGY; PATHOLOGY DERMATOPATHOLOGY;

CARCINOMA, BASAL CELL; DERMIS; FEMALE; HUMANS; KERATOSIS, ACTINIC; MALE; MELANOMA; RETROSPECTIVE STUDIES; SKIN NEOPLASMS;

EID: 84888642628     PISSN: 03036987     EISSN: 16000560     Source Type: Journal    
DOI: 10.1111/cup.12235     Document Type: Article

References (18)

1. Furue M,. Epithelial tumor, invasion and stroma. Ann Dermatol 2011; 23: 125.
2. Kaur P, Mulvaney M, Carlson JA,. Basal cell carcinoma progression correlates with host immune response and stromal alterations a histologic analysis. Am J Dermatopathol 2006; 28: 293.
3. Forman SB, Ferringer TC, Peckham SJ, et al. Is superficial spreading melanoma still the most common form of malignant melanoma? J Am Acad Dermatol 2008; 58: 1013.
4. Cockerell CJ,. Histopathology of incipient intraepidermal squamous cell carcinoma ("actinic keratosis"). J Am Acad Dermatol 2000; 42: 11.
5. King R,. Lentiginous melanoma. Arch Pathol Lab Med 2011; 135: 337.
6. Billano RA, Little WP,. Hypertrophic actinic keratosis. J Am Acad Dermatol 1982; 7: 484.
7. Massi G, LeBoit PE,. Regressing and regressed melanoma. In Histological diagnosis of nevi and melanoma. Darmstadt: Steinkopff Verlag, 2004; 617.
8. Sonis J,. How to use and interpret interval likelihood ratios. Fam Med 1999; 31: 432.
9. Landis JR, Koch GG,. The measurement of observer agreement for categorical data. Biometrics 1977; 33: 159.
10. Haupt HM, Stern JB, Dilaimy MS,. Basal cell carcinoma: clues to its presence in histologic sections when the initial slide is nondiagnostic. Am J Surg Path 2000; 24: 1294.
11. Ackerman A, Guo Y, Vitale P,. Clues to diagnosis in dermatopathology. Chicago: ASCP Press, 1992; 256.
12. Leboit P,. Stroma, interrupted. Am J Dermpath 2001; 23: 67.
13. Ackerman A, Reddy V, Soyer P,. Trichoblastic carcinoma. In Neoplasms with follicular differentiation, 2nd ed. New York: Ardor Shribendi, 2001; 625.
14. Lesack K, Naugler C,. Morphometric characteristics of basal cell carcinoma peritumoral stroma varies among basal cell carcinoma subtypes. BMC Dermatol 2012; 12: 1.
15. Moy RL, Moy LS, Matsuoka LY, Bennett RG, Uitto J,. Selectively enhanced procollagen gene expression in sclerosing (morphea-like) basal cell carcinoma as reflected by elevated pro alpha 1(I) and pro alpha 1(III) procollagen messenger RNA steady-state levels. J Invest Dermatol 1988; 90: 634.
16. Abbas O, Richards JE, Mahalingam M,. Fibroblast-activation protein a single marker that confidently differentiates morpheaform/infiltrative basal cell carcinoma from desmoplastic trichoepithelioma. Mod Pathol 2010; 23: 1535.
17. Reed JA, McNutt NS, Albino AP,. Differential expression of basic fibroblast growth factor (bFGF) in melanocytic lesions demonstrated by in situ hybridization. Implications for tumor progression. Am J Pathol 1994; 144: 329.
18. Dalton SR, Gardner TL, Libow LF, Elston DM,. Contiguous lesions in lentigo maligna. J Am Acad Dermatol 2005; 52: 859.